Tilray Brands (TLRY) Change in Account Payables (2017 - 2020)
Tilray Brands' (TLRY) quarterly Change in Account Payables came in at -$15.2 million in Q1 2020, down 1399.31% YoY from $1.2 million in Q2 2019, and up 18.92% on a QoQ basis from -$18.8 million in Q4 2019.
Tilray Brands (TLRY) Change in Account Payables (2017 - 2020) Analysis & Trends
Tilray Brands (TLRY) has 4 years of Change in Account Payables data on file, last reported at -$15.2 million in Q1 2020.
- Quarterly Change in Account Payables fell 1399.31% year-over-year to -$15.2 million in Q1 2020, while the trailing twelve-month figure through Mar 2020 was $3.9 million (up 499.09% YoY) and the FY2020 annual result came in at -$20.5 million, down 202.41% from the prior year.
- Change in Account Payables advanced to -$15.2 million in Q1 2020, from -$18.8 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $38.9 million in Q3 2019 to a low of -$18.8 million in Q4 2019.
- A 4-year average of $1.3 million and a median of $147500.0 in 2017 frame the typical range for Change in Account Payables.
- The widest YoY moves for Change in Account Payables: up 1206.37% in 2019, down 2714.21% in 2019.
- Tracing TLRY's Change in Account Payables over 4 years: stood at $4.6 million in 2017, then tumbled by 84.25% to $718000.0 in 2018, then slumped by 2714.21% to -$18.8 million in 2019, then advanced by 18.92% to -$15.2 million in 2020.
- The last three Change in Account Payables figures came in at -$15.2 million (Q1 2020), -$18.8 million (Q4 2019), and $38.9 million (Q3 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Tilray Brands | 516.11 Mn | 281.48 Mn | 90.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | -15.22 Mn |
| Mar 31, 2020 | -15.22 Mn |
| Dec 31, 2019 | -18.77 Mn |
| Dec 31, 2019 | -18.77 Mn |
| Sep 30, 2019 | 38.93 Mn |
| Sep 30, 2019 | 38.93 Mn |
| Mar 31, 2019 | -1.02 Mn |
| Mar 31, 2019 | -1.02 Mn |
| Dec 31, 2018 | 718,000.00 |
| Dec 31, 2018 | 718,000.00 |
| Sep 30, 2018 | -3.52 Mn |
| Sep 30, 2018 | -3.52 Mn |
| Jun 30, 2018 | 4.47 Mn |
| Jun 30, 2018 | 4.47 Mn |
| Mar 31, 2018 | 3.55 Mn |
| Mar 31, 2018 | 3.55 Mn |
| Dec 31, 2017 | 4.56 Mn |
| Dec 31, 2017 | 4.56 Mn |
| Sep 30, 2017 | -423,000.00 |
| Sep 30, 2017 | -423,000.00 |